Correlation Between Qualigen Therapeutics and National Capital
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and National Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and National Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and National Capital Bank, you can compare the effects of market volatilities on Qualigen Therapeutics and National Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of National Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and National Capital.
Diversification Opportunities for Qualigen Therapeutics and National Capital
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Qualigen and National is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and National Capital Bank in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on National Capital Bank and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with National Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of National Capital Bank has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and National Capital go up and down completely randomly.
Pair Corralation between Qualigen Therapeutics and National Capital
Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the National Capital. But the stock apears to be less risky and, when comparing its historical volatility, Qualigen Therapeutics is 14.42 times less risky than National Capital. The stock trades about -0.04 of its potential returns per unit of risk. The National Capital Bank is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest 16,200 in National Capital Bank on August 31, 2024 and sell it today you would lose (7,700) from holding National Capital Bank or give up 47.53% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 59.52% |
| Values | Daily Returns |
Qualigen Therapeutics vs. National Capital Bank
Performance |
| Timeline |
| Qualigen Therapeutics |
| National Capital Bank |
Qualigen Therapeutics and National Capital Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Qualigen Therapeutics and National Capital
The main advantage of trading using opposite Qualigen Therapeutics and National Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, National Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in National Capital will offset losses from the drop in National Capital's long position.| Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
| National Capital vs. Delhi Bank Corp | National Capital vs. CCSB Financial Corp | National Capital vs. Bank of Utica | National Capital vs. BEO Bancorp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |